Form 4: Hologic Inc. Executive Stephen MacMillan Reports Stock Transaction

Hologic Inc.'s Chairman, President, and CEO, Stephen MacMillan, reported a transaction involving the withholding of shares for tax obligations and the holding of restricted stock units.

Summary

• Stephen MacMillan, Chairman, President, and CEO of Hologic Inc., filed a Form 4 indicating a transaction on November 14, 2024.
• The transaction involved the withholding of 6,860 common stock shares to cover tax obligations related to the settlement of restricted stock units.
• Following the transaction, MacMillan directly owns 1,234,278 shares of Hologic common stock.
• He also indirectly owns 1,146,829 shares through the MacMillan Family Trust.
• The direct holdings include 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred.

Sentiment

Score: 5

Explanation: The document is a routine filing of a stock transaction, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The transaction is typical for executives who receive stock-based compensation, where shares are often withheld to cover tax obligations upon vesting.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine tax withholding related to executive compensation.

Key Dates

Keywords

Hologic Inc, Stephen MacMillan, Form 4, stock transaction, restricted stock units, tax obligations, beneficial ownership, executive compensation